DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPA.

Suppr

超能文献

作者信息

Hare T A, Beasley B L, Chambers R A, Boehme D H, Vogel W H

出版信息

Clin Chim Acta. 1973 May 18;45(3):273-80. doi: 10.1016/0009-8981(73)90438-5.

DOI:10.1016/0009-8981(73)90438-5

PMID:4708057

Abstract

摘要

相似文献

DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPA.

Clin Chim Acta. 1973 May 18;45(3):273-80. doi: 10.1016/0009-8981(73)90438-5.

Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease.接受左旋多巴治疗的帕金森病患者血浆和尿液中的氨基酸及多巴水平。

J Lab Clin Med. 1971 Feb;77(2):319-25.

[Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia].

Prensa Med Mex. 1972 Jul-Aug;37(7):246-50.

3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease.

Clin Chim Acta. 1972 Mar;37:359-69. doi: 10.1016/0009-8981(72)90456-1.

CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.帕金森病患者脑脊液和血浆中游离去甲肾上腺素、多巴胺、3,4-二羟基苯乙酸（DOPAC）、3,4-二羟基苯丙氨酸（DOPA）及肾上腺素的浓度

Acta Neurol Scand. 1995 Aug;92(2):116-21. doi: 10.1111/j.1600-0404.1995.tb01023.x.

Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.用左旋多巴和脱羧酶抑制剂治疗帕金森病。

Z Neurol. 1972;202(1):1-20. doi: 10.1007/BF00316422.

Effect of L-dopa on plasma free fatty acids and plasma glucose.左旋多巴对血浆游离脂肪酸和血糖的影响。

Metabolism. 1972 Jul;21(7):611-7. doi: 10.1016/0026-0495(72)90085-6.

An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy.对六名对左旋多巴治疗无反应的帕金森病患者的分析。

J Neurol Neurosurg Psychiatry. 1973 Jun;36(3):362-7. doi: 10.1136/jnnp.36.3.362.

L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.帕金森病的左旋多巴治疗：血浆左旋多巴浓度、治疗反应及副作用。

Mayo Clin Proc. 1971 Apr;46(4):231-9.

Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L-3,4-dihydroxyphenylalanine (L-dopa).

Neurology. 1971 May;21(5):540-9. doi: 10.1212/wnl.21.5.540.

引用本文的文献

Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases.代谢组学作为开发神经退行性疾病新治疗策略的关键工具。

Metabolites. 2022 Sep 14;12(9):864. doi: 10.3390/metabo12090864.

Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.帕金森病患者脑脊液中的氨基酸和生物胺

Neurochem Res. 2003 Aug;28(8):1145-50. doi: 10.1023/a:1024255208563.

[Biosynthesis of amino acids from glucose in the central nervous system in the Parkinson syndrome].帕金森综合征中中枢神经系统内由葡萄糖合成氨基酸的过程

Arch Psychiatr Nervenkr (1970). 1983;233(5):397-408. doi: 10.1007/BF00346090.

"On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma.帕金森病的“开-关”现象：与血浆中多巴浓度的相关性

J Neural Transm. 1984;59(3):229-40. doi: 10.1007/BF01250010.

Clinical pharmacokinetics of anti-parkinsonian drugs.抗帕金森病药物的临床药代动力学

Clin Pharmacokinet. 1987 Sep;13(3):141-78. doi: 10.2165/00003088-198713030-00002.

Parkinsonian abnormality of foot strike: a phenomenon of ageing and/or one responsive to levodopa therapy?帕金森病足跟着地异常：一种衰老现象和/或对左旋多巴治疗有反应的现象？

Br J Clin Pharmacol. 1990 Feb;29(2):179-86. doi: 10.1111/j.1365-2125.1990.tb03617.x.

Clinical pharmacokinetics of levodopa in parkinson's disease.帕金森病中左旋多巴的临床药代动力学

Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验